Lanean...
Therapeutic advances in idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is characterised by progressive accumulation of scar tissue in the lung and is associated with a median life expectancy of 2–4 years. Until recently, treatment options were limited, focusing on ineffective anti-inflammatory therapy, palliation, transplant or trial...
Gorde:
| Argitaratua izan da: | Clin Med (Lond) |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Royal College of Physicians
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4954329/ https://ncbi.nlm.nih.gov/pubmed/26833513 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7861/clinmedicine.16-1-42 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|